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I. SUMMARY 
 
The Healthcare Reform Act of 2006 required that the Department of Public Health (DPH)1 “implement a proactive 
statewide infection prevention and control program . . . in licensed health care facilities following protocols of the 
Centers for Disease Control and Prevention (CDC) for the purposes of implementation and adherence to infection 
control practices. . .”   In partnership with the Betsy Lehman Center for Patient Safety and Medical Error 
Reduction (BLC), DPH created a program for the prevention and control of healthcare associated infections (HAI) 
in acute care hospitals.   
 
The goal of the program is to reduce the incidence of those infections acquired in acute care hospitals.  Each of 
the following contributes to the goal. 
1) Reports of Outcome Measures help hospitals benchmark their performance against a national norm and 
provide greater transparency to the public and other stakeholders. 
2) Evidence Based Best Practices promote optimal infection prevention and control programs for use by 
hospitals. 
3) Professional Education provides healthcare professionals with current knowledge and a forum for the 
sharing of best practices. 
4) Public Awareness campaigns inform the pubic of what they can do to prevent infections. 
 
The program is responsive to legislative mandates and to recommendations of the Health Care Quality and Cost 
Council (HCQCC), chaired by Dr. JudyAnn Bigby, Secretary of Health and Human Services.  The HCQCC 
established specific goals and milestones including the first aggregate report be completed by March of 2009.  
This preliminary report covers a period from July 1, 2008 to October 31, 2008.   
 
Sixty six of Massachusetts’ 74 acute care hospitals are represented in the report.  Most of the hospitals are non-
teaching hospitals.  Acute care hospitals in Massachusetts range in size from fewer than 100 beds to more than 
300 beds.  See Appendix 1 for a list of all acute care hospitals in the state.  Hospitals reported their data through 
the National Healthcare Safety Network (NHSN), which is the surveillance system developed by CDC.  
    
The infection measures in this report were recommended by an Expert Panel organized at the inception of the 
program and was chosen on the basis of frequency, severity and preventability.  The first public report presents 
data on central venous catheter associated bloodstream infections (CVC-BSI) for patients in intensive care units, 
(ICU) and on deep surgical site infections (SSI) arising from knee and hip arthoplasty. 
 
Hospitals collect data on other measures that are not being made public at this time.  These are measures whose 
definitions and/or methodology need further assessment to determine if they are accurate and useful for public 
reporting.  Some of these measures are reported to BLC. Additional measures are being reported only within 
hospitals for their own internal quality monitoring.  See Appendix 2 for a chart of all infections being monitored and 
the status of reporting.   
 
Hospitals are collecting race and ethnicity data based on Massachusetts’ expanded list of codes.  The data are 
collected through NHSN, but hospitals are using custom fields to enter the data.  Race and ethnicity data are not 
available for this report because the custom fields were recently created and therefore were not collected during 
this reporting period.  DPH plans to report these data in the October, 2009 report. 
 
Sixty-six acute care hospitals reported data on CVC-BSIs.  During the reporting period, these hospitals reported a 
total of 50 criterion 1 CVC-BSIs in their adult and pediatric ICUs.  The 5 hospitals reporting data from neonatal 
ICUs (NICU), reported 6 CVC-BSIs.  .  Finally, hospitals reported a total of 7 SSIs arising from total primary knee 
arthroplasty and 10 SSIs resulting from total or partial primary hip arthroplasty. 
 
In addition to the reporting of specific measures of infection, DPH and BLC have initiated other activities related to 
the prevention of HAIs.  John Snow Research and Training Institute (JSI) is the primary contractor for the 
program, with staff experienced in infection prevention activities.  JSI provided resources for the production of the 
Expert Panel’s final report as well as expertise for many aspects of data collection and analysis.  JSI conducted a 
methicillin-resistant Staphylococcus aureus (MRSA) point prevalence survey in September 2008 to determine the 
extent of MRSA infection and colonization in acute care hospitals.  A second point prevalence study is planned for 
the fall of 2009 to validate results and measure progress.  JSI is also collecting data on influenza vaccination of 
1 The Bureau of Disease Prevention Response and Services (BIC) and the Bureau of Health Care Safety and 
Quality (BHCSQ) who contributed to the program are part of the Department of Public Health. 
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hospital employees for October 2008 through March 2009.  The MRSA and vaccination data is being reported to 
BLC.    
 
The Division of Healthcare Quality (DHCQ) within DPH employs two nurses who are experienced infection 
preventionists.  They developed a tool to assess infection prevention programs in acute care hospitals.  They 
have completed visits to 50% of the hospitals.  These visits provide information in areas where the hospitals may 
have need of consultation. 
 
As of October, 2008, Massachusetts is one of 25 states that require mandatory public reporting of HAIs.  Nineteen 
of these states are using NHSN.  Hospitals have been learning how to collect data using standardized definitions 
they may not have used before.  NHSN is new to most hospitals so they are becoming familiar with different 
system requirements.  These challenges have led to initial data problems.  None-the-less, the advantages of 
NHSN outweigh these challenges in terms of its long-term development as an application, its use of consensus 
definitions and its ability to provide benchmarks of performance from other states. 
 
This report covers 4 months of data collection.  Since the time period is short and technical difficulties with NHSN 
have been encountered, the numbers are small and great care must be taken with interpretation.  Some 
comparisons to the NHSN national published data are presented.  The national data represents a very much 
larger sample of hospitals and events observed over two years.  As additional data are collected and analyzed, 
there will be ample opportunity for more in-depth analysis and comparisons. 
 
The next public report is planned for October, 2009.  That report will include hospital specific information on CVC-
BSIs and SSIs.  It is expected that the October report will also present aggregate data for: criterion 2 CVC-BSIs 
(skin contaminants), abdominal and vaginal hysterectomy SSIs, and SSIs resulting from coronary artery bypass 
grafts (CABG) surgery.  If the number of events is large enough, data will be stratified by race and ethnicity.  
Additionally, aggregate data will be presented for the influenza vaccination of hospital employees and possibly for 
the MRSA prevalence studies.   
 
The report also contains sections on NHSN, Lessons Learned and Future Plans.  The section on NHSN includes 
issues related to NHSN adoption and implementation.  The Lessons Learned section discusses issues related to 
the process of developing the program.  The Future Plans section discusses the October report and longer term 
activities of the program. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II. BACKGROUND  
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Healthcare reform (Chapter 58 of the Acts of 2006) required that DPH develop a healthcare associated infection 
prevention and control program to reduce HAIs.  HAIs are a cause of preventable illness and death.  It is 
estimated that 2 million patients develop one or more HAIs resulting in 90,000 deaths annually.2  In addition to the 
legislative mandate, consumer groups have also called for mandatory public reporting of HAIs. 
  
In order to implement the program, DPH, BLC and BID convened a panel of experts including hospitals, 
academia, organizations, professional associations and consumer advocacy.  The Expert Panel’s charter was the 
development of a comprehensive program in accordance with the Healthcare Reform Act.   
 
The Expert Panel issued a final report3 in January, 2008 and recommended that the program begin with acute 
care hospitals and recommended outcome measures, evidence based best practices and data reporting 
requirements.  The Panel further recommended that outcome and process measures be reported in three tiers so 
that measures with poorly defined definitions and/or unresolved methodology issue could be examined prior to 
public release.  See Appendix 2.   
 
The reporting tiers are:   
 
1. DPH – public data for use by consumers, insurers and stakeholders 
2. BLC – data for monitoring and quality improvement purposes, but not initially publicly disseminated 
pending assessment of the adequacy of definitions and methodology 
3. Internal – data for tracking performance. 
 
The Panel also recommended that data be reported through the NHSN created by the CDC.  NHSN provides 
uniform definitions and a national database for comparison purposes.    
 
Following up on these recommendations, DPH amended hospital licensure regulations 105 CMR 130.000 in 
February, 2008.  The regulation established NHSN as the platform for data collection and submission, required 
hospitals grant separate and specific access to the data to DPH and BLC, set deadlines by which these elements 
needed to be accomplished and required hospitals follow DPH guidelines.  By April of 2008, all hospitals had 
enrolled in NHSN and in July, 2008 hospitals began submitting data.   
 
While the outcome measures provide one kind of information, the best practices recommended by the Expert 
Panel provide information about the prevention of infection.  JSI, the program contractor, conducted an extensive 
literature review to compile a list of best practices. The Expert Panel then ranked each on strength of evidence 
and strength of the recommendation.  There are a total of 324 best practices falling into one of eight categories.  
The number in parenthesis is the number of best practices for that category. 
1. Hand Hygiene (27) 
2. Standard Precautions (34) 
3. Contact Precautions (10) 
4. Environmental Measures for Prevention and Management of multi-drug Resistant Organisms (8) 
5. Prevention of Ventilator-Associate Pneumonia (20) 
6. Prevention of Surgical Site Infections (52) 
7. Prevention of Bloodstream Infections (103) 
8. Prevention of Catheter-Associated Urinary Tract Infections (40) 
 
The scope and content of current hospital programs provide a context for understanding outcome measures and 
best practices.  In this vein, JSI developed a survey to look at hospital characteristics, surveillance activities, 
prevention activities and data capacity.  Sixty eight hospitals responded to the survey.  Information specific to 
CVC-BSIs and SSIs are included in those specific sections.   
 
 
 
 
Of the hospitals responding to the survey, the largest proportion of hospitals (56%) were non-teaching community 
hospitals, the second largest (38%) community teaching hospitals and the remainder university hospitals.  The 
average bed size is 229 with the largest, 621 beds, in a university teaching hospital and the smallest (150) beds in  
a non-teaching community hospital.  All but one hospital have ICUs with a mean of 25 ICU beds.   Almost half of 
the hospitals had medical residents in training and 97% had nursing students.   
2 Burke, JP. (2003). Infection Control – A Problem for Patient Safety. New England Journal of Medicine 
13:348(7):651-6 
3 The Final Report can be found at www.mass.gov/dph/dhcq. 
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All hospitals perform internal surveillance for blood stream infections, surgical site infections and MRSA.  Most 
hospitals were involved in special initiatives to decrease BSIs and SSIs.  Ninety one percent had initiatives to 
reduce BSIs and 97% had activities related to reducing SSIs. 
 
JSI also conducted focus group interviews with hospital executives for additional insights.  Primary concerns and 
program elements to address them are: 
 
HOSPITAL CONCERNS PROGRAM ELEMENTS 
Uniformity of data collection and consistent 
use of definitions 
NHSN requires uniform data collection and standardized 
definitions 
Inaccurate comparisons between hospitals The CVC-BSI data is stratified by type ICU.  The SSI data will be 
stratified when the sample is larger. 
Accountability for preadmission infections NHSN definitions include a time frame for measuring the onset of 
an infection. 
Burden of data collection This is data that for the most part hospitals are already collecting, 
but DPH is aware of the burden. 
Public understanding of the data The report is written to serve the needs of multiple constituencies. 
Focus on prevention DPH is making visits to each hospital to provide education and 
consultation. 
 
In addition to the support that JSI provided, DPH formed partnerships with the Coalition for the Prevention of 
Medical Errors and the Partnership for Healthcare Excellence.  The Coalition has held a number of seminars for 
professionals on infection prevention and for the sharing of effective strategies.  The Partnership has provided a 
fact sheet to raise public awareness and address the steps they can take to reduce infection.  The fact sheet has 
also been translated in Spanish.  Stakeholders from associations and organizations involved with HAIs have also 
been involved. 
 
Following the completion of the Expert Panel’s work, DPH and BLC convened a Technical Advisory Group (TAG), 
consisting of members with expertise in infection prevention, patient safety and healthcare policy.  This group’s 
charter is to provide DPH, BLC and BID with advice on data analysis and interpretation.  For example they 
reviewed the early MRSA data and suggested that repeating the survey would be important to an analysis of the 
data.  The TAG will have an on-going role as additional reports are prepared. 
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III. FINDINGS 
 
Findings are preliminary in that only four months of data have been collected and analyzed, some hospitals are 
excluded from the report, the follow-up periods for observing HAIs have not expired and all of the data have not 
been validated.  The small number of events, over a short space of observation time, demands cautious 
interpretation. Raw numbers and rates of infections are presented for each infection type.  For CVC-BSI 
infections, rates of catheter utilization were similar to national rates, and are not reported here. 
 
A total of 66 hospitals are represented in this report.  The sample includes both teaching and non-teaching 
hospitals.  Bed size varied with 42 hospitals with a bed size of less than 200, 10 hospitals had a bed size of 
between 201 and 300 and the remainder (14) had greater than 300 beds.  Five of the hospitals reported NICU 
CVC-BSI data.  
 
A. Central Venous Bloodstream Infections 
Central venous catheters are inserted into one of the great vessels (e.g., sub-clavian vein, jugular vein) that 
terminate at or close to the heart.  A criterion 1 CVC-BSI is defined as occurring for the duration of catheter 
placement and for 48 hours thereafter, caused by a recognized pathogen cultured from one or more blood 
cultures and the cultured organism is not related to an infection at another site.  This report focuses on criterion 1 
CVC-BSIs that occur in Intensive Care Units (ICUs) -- the majority of temporarily inserted catheters are in ICU 
patients who are closely monitored. 
 
Over the four month reporting period, 50 criterion 1 CVC-BSIs were identified in pediatric and adult patients. One 
event was excluded from the rate due to missing denominator data.  Seven occurred in one pediatric 
cardiothoracic surgical ICU and were not aggregated with the larger number of pediatric ICU cases to be 
consistent with the national database.  The remaining 42 cases occurred across 16 hospitals.  Nine of the patients 
died, however CVC-BSI was implicated in any of the deaths.  Five hospitals reported a total of 6 NICU CVC-BSIs 
with 2 deaths, of which 1 was attributable to the infection.  See Appendix 3 for a list of pathogens. 
 
Tables 1shows data on CVC-BSI infection rates s for adult and pediatric ICUs.  The tables are stratified by type of 
ICU.  Rates provide a means of comparing infections across facilities, while stratification by type ICU provides 
some adjustment for interpretation by patient type and acuity.  To match the CDC methods, avoid small number 
effects and to report the maximum amount of data, the location types pediatric medical ICU and pediatric 
medical/surgical ICU were merged into the location type “Pediatric ICU”.  The locations surgical ICU, trauma ICU, 
burn ICU and neurosurgical ICU were merged into location type “Surgical and Trauma ICU”.    
 
For comparison to the national data, pediatric medical/surgical ICU was used as a comparison for the “pediatric” 
combined ICU.  The mean was calculated for comparison to the “Surgical/Trauma” ICU because these categories 
were disaggregated by hospital teaching type in the CDC report. 
 
CVC-BSI rates are calculated by using the aggregate number of cases divided by the aggregate number of days 
of central line insertion multiplied by 1000.  Central line days (utilization of a central line) are an indication of 
patient acuity and level of utilization.  Patients who have had a catheter inserted for a longer period of time tend to 
be sicker.  For adult patients, the highest rate was observed in Medical ICUs with a rate of 1.6 per 1000 line days.  
The lowest rate was observed in Surgical and Trauma ICUs with a rate of 0.3.  Pediatric ICUs had a rate of 1.8.    
 
Infection rates and utilization ratios for Massachusetts are compared to national NHSN published data for 2006-
2007.4  Both the national “pooled mean”, calculated by using the aggregate number of cases reported nationally 
divided by the aggregate number of central line days multiplied by 1000 and the national “median”, representing 
the rate in 50% of the NHSN national ICUs in the category of ICU, are provided.  Rates are based on a very small 
number of events over the short period of observation, so care must be taken in interpretation. 
 
 
 
 
 
 
                                                     
4 Edwards JR, Peterson KD, Andrus ML, Dudeck MA, Pollock DA, Horan TC; National Healthcare Safety Network 
Facilities.  National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued 
November 2008.  Am J Infect Control 2008; 36: 609-26. 
 
TABLE 1 
CENTRAL VASCULAR LINE BLOODSTREAM INFECTION RATES  
 MASSACHUSETTS (7/1/08-10/31/08) & NATIONAL NHSN DATA (2006-2007) 
 
 
ICU TYPE NO. 
OF 
ICUs 
NO.  OF 
CRITERION 
1 CVC-BSI 
CVC 
DAYS 
MA 
CRITERION 
1 CVC-BSI 
RATE* 
MA  ALL 
CVC-BSI 
RATE 
NATIONAL 
RATE 
(MEAN) 
NATIONAL 
RATE 
(MEDIAN) 
Coronary ICU 12 2 5101 0.4 1.0 2.1 1.3 
Cardiothoracic ICU 10 4 7427 0.5 0.5 1.4 1.2 
Medical ICU 15 17 10950 1.6 2.0 2.4 1.9 
Medical/Surgical ICU 46 9 15702 0.6 0.6 1.7 *** 
Surgical and Trauma 
ICU** 20 5 14460 0.3 
1.2 2.1 *** 
Pediatric ICU 7 5 2784 1.8 2.9 2.9 2.1 
 
 CVC-BSI rate= Number of CVC-BSI/Number of central line days x 1000 
 *Combination of criterion 1 CVC-BSI’s and all others reported by Massachusetts’ hospitals to NHSN allow for 
comparison with national rates (criteria 2 and 3 CVC-BSI are recorded, but not individually publicly reported at 
present).     
**Combined ICU types (Surgical, Trauma and Burn). 
***Median rates are not available from the national data due to how the data is disaggregated in the national 
reports. 
 
Tables 2 and 3 present NICU rates by birth weight.  Birth weight is used to stratify babies in the national data, but 
it should be recognized that babies may be admitted to NICUs, particularly tertiary care referral hospitals, well 
after birth.  
 
Table 3 presents the rate of infection (the total number of infections divided by central line days multiplied by 
1000) for criterion 1 CVC-BSIs in NICUs.  The rates for all CVC-BSIS (criteria 2 and 3 in addition to reportable 
criterion 1) are combined for comparison with national data.  National data provided for comparison is for level III 
NICUs, while state data is a combination of mostly level III and some level II/III NICUs. 
 
TABLE 2 
CENTRAL VASCULAR CATHETER BLOODSTREAM INFECTIONS IN NICUs 
MASSACHUSETTS (7/1/08 – 10/31/08) & NATIONAL NHSN DATA (2006 – 2007) 
 
BIRTH WEIGHT NO.OF 
NICUs 
NO. OF 
CRITERION 
1 CVC-BSIs 
 CVC 
DAYS 
CRITERION 
1 CVC-BSI 
RATE 
MA ALL 
CVC-BSI 
RATE* 
NATIONAL 
RATE 
(MEAN) 
NATIONAL 
RATE 
(MEDIAN) 
<= 750 g 5 2 650 3.1 4.6 3.7 2.3 
751-1000 g 5 2 563 3.6 3.6 3.3 2.4 
1001-1500 g 5 1 561 1.8 1.8 2.6 1.6 
1501-2500 g 5 0 477 0.0 0.0 2.4 1.1 
>2500 g 5 1 354 2.8 8.5 2.0 0.0 
CVC-BSI rate = number of CVC-BSI /number of central line days/central line days x 1000. 
*Combination of criterion 1 CVC-BSI’s and all others reported by Massachusetts’ hospitals to NHSN allow for 
comparison with national rates (criteria 2 and 3 CVC-BSI are recorded, but not individually publicly reported at 
present).     
 
Appendix 4 has additional tables with CVC-BSI percentiles which allow individual hospitals to compare their rates 
by ICU type to the group of Massachusetts hospitals reporting. 
 
 
B. Surgical Site Infections 
This report includes surgical site infections (infection of the deep tissue/prosthesis), following primary knee and 
hip arthroplasty (replacement of the joint with an artificial knee or hip).  Such infections may cause readmission to 
the hospital. The definition for these SSIs includes a follow-up of one year.  Surgical procedures for which 
infections are reported here occurred over the space of 4 months, so the longest follow-up is 4 months.  Thus, 
these infection rates would be low, as only less than 4 months and not the year of observation for infection were 
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completed. This will also be true of the October, 2009 report as almost all of the knee and hip replacements will 
not have had 1 year of follow-up. 
  
Seven cases of deep SSIs were found following knee arthroplasty and 10 cases following hip arthroplasty.  No 
deaths occurred in any of these patients.  The data are not stratified to adjust for risk since the numbers are small.   
Also, because of the small sample, a comparison to the national data is not possible.  
 
Table 5 
DEEP & ORGAN SPACE SURGICAL SITE INFECITON RATES 
 
SURGERY NUMBER OF DEEP 
& PROTHESIS SSIs 
NUMBER OF 
PROCEDURES 
MASSACHUSETTS 
RATE PER 100 
PROCEDURES 
Knee arthroplasty 7 5328 0.131 
Hip arthroplasty 10 4023 0.249 
              The SSI rate is calculated by dividing the number of infections by the number of procedures multiplied   
   by 100. 
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IV. THE NATIONAL HEALTHCARE SAFETY NETWORK    
 
NHSN is a secure, integrated, web-based monitoring system established by the CDC for hospitals to report HAI 
information confidentially.  There is no charge for the use of the system.  Definitions for data collection are 
standardized and internationally recognized.  Participation in NHSN allows facilities to monitor HAI data internally, 
compare themselves to similar institutions and to measure their results against a benchmark.  DPH, BLC, BIC can 
do likewise with explicit permission from hospitals.  This information is used to guide quality improvement aimed 
at reducing HAIs.  
 
Key features of NHSN include: 
• Confidentiality of the data is guaranteed by CDC; state agencies are able to view and analyze data only 
after hospitals provide access using the NHSN group feature. 
• Participation in NHSN requires facilities to agree to follow specific CDC HAI protocols and definitions.  
Facility specific data is immediately available to hospitals, NHSN, and government agencies for viewing 
and analysis. 
• Hospitals are authorized to view only their own facility specific information. 
• NHSN has optional custom fields used for unique requirements that states may have, such as 
Massachusetts’ race and ethnicity coding. 
• NHSN provides initial and on-going training and technical assistance for hospitals on enrollment, data 
collection and submission.   
• CDC formed an NHSN user group that provides technical support and training for state users.   
• NHSN collaborates with other organizations focused on promoting scientifically accepted principles of 
infection prevention (i.e. Society of Healthcare Epidemiology of America, Association for Professionals in 
Infection Control and Epidemiology, Inc., Infectious Disease Society of America, etc.). 
• Maintenance of the NHSN site and upgrades to the system are provided by CDC with no cost to users.  
• NHSN routinely publishes reports of national aggregated HAI data.  
 
Challenges associated with NHSN include: 
• Enrollment was labor intensive and required that facilities complete a multi-step process.  
• Among the steps that proved particularly cumbersome was the granting of access rights to DPH and BLC 
so that they could view the data. 
• The system is inefficient in that it requires long waits between tasks.  NHSN also has outages that CDC is 
working to correct. 
• Hospitals with electronic data collection experienced varying degrees of difficulty aligning their system 
with NHSN. 
• NHSN does not include a process to validate the accuracy of data submitted, though checks for 
agreement among data elements have recently been built in. 
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V. OTHER ACTIVITES 
 
While the public reporting of acute care hospital data has had precedence, DPH and BLC have initiated other 
activities to advance the goal of producing a comprehensive Infection Prevention and Control Program.  
 
A. MRSA Point Prevalence 
JSI conducted a MRSA point prevalence study to determine the number of MRSA infection and colonization in 
acute care hospitals on a single day.  DPH and BLC are planning a second point prevalence study to enhance the 
utility of the findings after which time aggregate data will be reported.   
 
B. Influenza Vaccinations of Hospital Employees 
JSI also conducted a survey of influenza vaccinations administered to hospital employees for the influenza 
season that runs from November 2009 through March 2009.  It included all employees (direct care, administrative 
and environmental workers).  The data were collected for those immunizations hospitals administered with an 
optional reporting of vaccinations received outside of the hospital program.  DPH and BLC are planning on 
aggregate reporting in October. 
 
C. Assessment Visits 
Two infection preventionists in the Division of Healthcare Quality developed a tool that enables acute care 
hospitals to conduct assessments of their own infection programs.  The intent is to aid hospitals in understanding 
the spectrum of programmatic components, policies and procedures in their own operations.  The assessment is 
based on 20 of the best practices recommended by the Expert Panel.  The preventionists are working with 
hospitals as partners in implementing these best practices.  
 
The preventionists first send a questionnaire (the tool) to hospitals for completion and then follow-up with an on-
site visit.  The site visits provide an opportunity to confirm information and provide hospitals with education about 
optimal infection prevention practices.  The tool and visits are for the purpose of assessment only and are not a 
compliance survey.   
 
The Assessment Tool provides guidance in the following areas: 
1. Priorities: general question about significant program elements 
2. Infection Prevention Committee: composition, meeting frequency and information dissemination 
3. NHSN: problems and/or questions about the software used for reporting infections 
4. MRSA Point Prevalence: questions about the study5 
5. Process Measures: processes related to surgical site infections, central lines, hand hygiene and 
ventilator associated pneumonia 
6. Surveillance: procedures related to tracking infections 
7. Department Resources: staffing levels 
8. Education: competency of staff, information for patients and families 
9. Isolation Precautions: approaches to identify patients requiring isolation 
10. Environment: equipment and room cleaning. 
  
D. Other Facility Types 
Under the umbrella of the HCQCC, DPH and BLC have expanded the scope of the program to include 3 other 
types of facilities.  They are: ambulatory surgical centers, extended care (long-term care, long-term acute care 
and rehabilitation hospitals) and dialysis centers.  The same process used in acute care hospitals are being 
applied to these facilities, though in a more limited way.  All groups have met at least once and have established 
on-going meeting schedules.  Each group will: 
1. Identify those best practices relevant to their patient/resident population 
2. Identify outcome measure(s) 
 Each group has preliminarily identified collecting the number of employees vaccinated for influenza as 
 one outcome measure. 
3. Discuss technical training and professional education needs 
4. Discuss public awareness campaigns. 
 
E. Training and Education 
5 The first phase of data collection was completed in September, 2008.  Phase 2 data collection is expected in the 
fall of 2009. 
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Training of several different kinds took place in the reporting period.  The first was technical training on using 
NHSN, conducting the MRSA point prevalence study and conducting the employee influenza vaccination survey.  
The second type of training was largely done by the Coalition for the Prevention of Medical Errors.  The Coalition 
provided professional training on best practices. 
 
1. Technical Training 
 Prior to enrolling in NHSN, all users are required to take NHSN’s web based training.  Facility  
 Administrators, Group Administrators and Users (those other than Facility or Group Administrators) are 
required to watch an Overview of NHSN, NHSN Enrollment and Facility Start-up modules and read the 
NHSN Manual – Patient Safety Protocol.  Additionally, all must view the specific modules for which they 
will be collecting data (e.g., procedure associated module).  The Administrators must also view modules 
specific to their tasks. 
 
 JSI provided additional training in the form of webinars to supplement the NHSN training.  The webinars 
“walked” hospitals through the process of enrolling, obtaining a digital certificate and conferring rights.  
Webinars were also conducted on the unique requirements for the point prevalence study and influenza 
vaccination survey.  An additional webinar was presented on how to implement Massachusetts 
requirement for reporting an expanded list of race and ethnicity codes.  
 
2. Professional Education 
 The Coalition for the Prevention of Medical Errors has conducted 14 programs between 2007 and the first 
part of 2009 using subject matter experts from across the country.  Nine hundred participants attended 
these programs.  Among the topics covered in these programs were: the challenge of identifying 
ventilator associated pneumonia, identifying and treating sepsis, choosing a surveillance system, keys to 
executive support and a team approach to HAIs.  The Coalition also serves as a clearing house of current 
literature, other worthwhile programs and meeting schedules of various stakeholders.  They maintain an 
extensive distribution list including all of the acute care hospitals in the state. 
 
It is too early in the program’s history to assess the impact that training and education might have on HAI rates.   
Many factors can contribute to a reduction of the incidence of HAI, among them training and education.  Other 
factors influencing HAI rates include public reporting, hospital’s own initiatives, public awareness and advances in 
treatment.  The first step in assessing rates will be a year-to-year comparison of rates which will occur after two 
full years of data collection. 
 
F.  Public Awareness 
The Partnership for Healthcare Excellence has created a fact sheet on hand hygiene for the public which provides 
helpful information about those preventive measures the public can adopt.   The sheet has been translated into 
Spanish. The sheets have been distributed in the communities served by the Partnership and to hospitals.  The 
Partnership estimates that it has had approximately 220 downloads from its website, many from hospitals that are 
customizing the fact sheets for their own use.   
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VI. LESSONS LEARNED 
 
The lessons learned in the development and implementation of the program from its inception to this 
preliminary report is:  
 
• Prevention and control of HAI must be embedded in an organization’s overall quality and safety 
program.  
• Support and buy-in from leadership at the highest institutional level are crucial to the implementation 
of HAI reporting.   
• NHSN is a nationally recognized system for reporting, evaluating and comparing HAI data. While 
acknowledging the guidance and technical support DPH has received from NHSN, NHSN has 
limitations associated with the system.  Entering data is resource intensive for infection preventionists 
and users who are required to follow NHSN rules.   
• Educating healthcare personnel on the best practices for prevention of HAIs is a significant 
component of this initiative.  
• There is variation in the ability of hospitals to use existing systems to transmit data electronically. This 
increases the burden of data collection. 
• Many infection prevention and control departments are under-resourced, and the new reporting 
requirements place additional demands on infection preventionists.   
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VII. FUTURE PLANS 
 
These plans represent the continuation of activities already undertaken supplemented by other ones as 
recommended by the Expert Panel.  
 
• DPH will implement a system for validation consistent with protocols under development by CDC to 
ensure accuracy and timeliness of data submitted. 
• DPH will develop a process to evaluate data submission for reliability and consistency in the 
application of the surveillance definitions.   
• DPH will continue the ongoing collaboration with BLC, BID and additional stakeholders in the 
development of HAI reports which are accurate, complete and meaningful to the public, hospitals and 
healthcare providers.   
• DPH will review and document hospital compliance with mandated reporting.   
• DPH will continue to support HAI prevention and NHSN training initiatives.  
• DPH will continue to look for additional ways to promote broader involvement of patients and 
consumer groups in this important initiative.   
• DPH will consider additional methods for risk adjustment of the data to provide fair interfacility 
comparisons of infection rates.  
• DPH will continue the expansion of the program to other facility types. 
• DPH will advocate for dedicated funding and resources to support the implementation of a 
comprehensive, statewide Infection Prevention and Control Program.  
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Appendix 1 
ACUTE CARE HOSPITALS IN MASSACHUSETTS 
Addison-Gilbert* Mount Auburn Hospital 
Anna Jaques Hospital* Nantucket Cottage Hospital* 
Athol Hospital Nashoba Valley Medical Center* 
Baystate Mary Lane Hospital* New England Baptist Hospital 
Baystate Medical Center Newton-Wellesley Hospital 
Berkshire Health Systems Noble Hospital 
Beth Israel Deaconess Hospital - Needham  North Shore Medical Center ** 
Beth Israel Deaconess Medical Center Northeast Hospital - Addison Gilbert Hospital 
Boston Medical Center Northeast Hospital - Beverly Hospital 
Brigham and Women's Hospital Nthern Berkshire Health Sys(Nth Adams Reg Hos) 
Signature Healthcare - Brockton Hospital Quincy Medical Center 
Cambridge Health Alliance - Cambridge Hospital Saint Vincent Hospital 
Cambridge Health Alliance - Somerville Hospital Saints Memorial Medical Center 
Cambridge Health Alliance - Whidden Memorial  Shriner's Hospital for Children – Boston* 
Cape Cod Hospital Shriner's Hospital for Children - Springfield  
Caritas Carney Hospital Signature Healthcare - Brockton Hospital 
Caritas Good Samaritan Medical Center South Shore Hospital  
Caritas Holy Family Hospital Southcoast Health Systems -- Charlton Hospital 
Caritas Norwood Hospital Southcoast Health Systems -- St. Luke's Hospital 
Central New England Health Alliance Southcoast Health Systems -- Tobey Hospital 
Children's Hospital St. Anne's Hospital 
Clinton Hospital St. Elizabeth's Medical Center  
Cooley Dickinson Hospital Sturdy Memorial Hospital  
Emerson Hospital Tufts New England Medical Center 
Fairview Hospital U Mass Memorial  Medical Center 
Falmouth Hospital Winchester Hospital 
Faulkner Hospital Wing Memorial Hospital 
Franklin Medical Center  
Hallmark Health Corp -- Lawrence Memorial   
Hallmark Health Corporation -- Melrose - Wakefield  
Harrington Memorial Hospital  
Heywood Hospital  
Holyoke Hospital  
Hubbard Regional Hospital  
Jordan Hospital  
Lahey Clinic Hospital  
Lawrence General Hospital  
Lowell General Hospital  
Marlborough Hospital  
Martha's Vineyard Hospital  
Massachusetts Eye & Ear Infirmary  
Massachusetts General Hospital  
Mercy Medical Center*  
Merrimack Valley Hospital  
Metro West Medical Center - Framingham Hospital  
Metro West Medical Center -- Leonard Morse Hos  
Milford Regional Hospital  
Milton Hospital  
Morton Hospital and Medical Center  
*These hospitals have been excluded from the analysis for technical reasons.  Though in compliance as of 
3/16/09, Anna Jacques, Mercy, Nashoba Valley, Shriners Boston are still excluded. 
** Union and Salem hospitals are a part of North Shore Medical Center.  They are combined in this report, but will 
be separated in the October 2009 report. 
 
 
Appendix 2 
Summary Chart of HAI-Related Measures as recommended by the 
Massachusetts Expert Panel, January 31st  2008 
 
 
 
  HAI Measures Approved by Expert Panel 
Reporting Level Outcome Measures 
Public 1  BLC 2 Internal 3
 
 
9 CVC-BSI in ICUs – true pathogens  
          (CDC criterion 1)* ♦   
9 CVC-BSI in ICUs – skin  
         contaminants   
 ♦  
9 CVC-BSI outside of ICUs – true   
          pathogens and skin  contaminants    
          (CDC  criterion 1 and 2)* 
  ♦ 
9 SSI resulting from hip arthroplasty ♦   
9 SSI resulting from knee arthroplasty ♦   
9 SSI resulting from hysterectomy  
         (vaginal and abdominal) 
 ♦  
9 SSI resulting from coronary artery   
         bypass graft 
 ♦  
9 Ventilator-Associated Pneumonia   
         (VAP) 
  ♦ 
         Point prevalence of methicillin- 
         resistant   Staphylococcus  aureus   
        (MRSA) 
 ♦  
         Clostridium difficile-associated        
         disease  (CDAD)   ♦ 
Process Measures 
        VAP prevention: Daily application of  
        protocol-driven assessments for   
        ventilation  
 ♦  
        VAP prevention: Elevation of the    
         head of the patient’s bed  ♦  
Influenza vaccination of healthcare   
       workers (new to NHSN for 2008) 
 
 ♦  
9 measure found in the National Healthcare Safety Network (NHSN) 
 
1 Public – Data submitted to the Department of Public Health 
2 BLC – Betsy Leman Center for Patient Safety and Medical Error Reduction 
3 Internal – For reporting hospital’s own use only 
CVC-BSI – central-venous catheter-associated bloodstream infection 
ICU – intensive care unit 
SSI – surgical site infection 
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Appendix 3 
CAUSATIVE ORGANISMS IN CVC-BSIs 
 
 
ADULTS & PEDIATRIC 
 
Etiology Criteria 1 BSIs 
Enterococcus species 12 
Gram negative organism 12 
Yeast 10 
Staphylococcus aureus  7 (5 MRSA) 
Gram positive and Gram negative organisms 4 
Streptococcus species 1 
Enterococcus species + coagulase negative 
staphylococcus 
4 
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Appendix 4 
CENTRAL LINE VENOUS CATHETER BLOODSTREAM INFECTIONS (CVC-BSI) 
EXTENDED TECHNICAL INFORMATION 
 INCLUDING PERCENTILES OF DISTRIBUTION OF MASSACHUSETTS INFECTION RATES (7/1/08-10/31/08) 
 
TABLE 4-1 
CRITERION 1 CENTRAL LINE BLOODSTREAM INFECTIONS RATES (7/1/08-10/31/08)   
WITH MASSACHUSETTS PERCENTILES 
 
MA PERCENTILES* 
ICU TYPE 
NO. 
OF 
ICUs 
NO. 
OF 
CVC-
BSIs 
CENT
RAL 
LINE 
DAYS 
CVC-
BSI 
RATE 10% 25% 50% 75% 100% 
Coronary  12 2 5101 0.4 0.0 0.0 0.0 0.0 1.7 
Cardiothoracic 10 4 7427 0.5 0.0 0.0 0.0 0.0 3.3 
Medical ICU 15 17 10950 1.6 0.0 0.0 2.9 2.9 3.7 
Medical/Surgical  46 9 15702 0.6 0.0 0.0 0.0 0.0 0.9 
Surgical and Trauma  20 5 14460 0.3 0.0 0.0 0.0 0.4 1.8 
Pediatric  7 5 2784 1.8 0.0 0.0 0.0 2.8 3.0 
*A percentile shows the distribution of rates across the entire population.  For example, 50% of acute care 
hospitals included in this report had a rate of 2.9 in Medical ICUs. 
 
 
